Long Term Care Pharmacists

Clinical Support Services (CSS) has redesigned the pharmacy consulting process to provide better service and improved accountability for facilities required to meet Federal medication review requirements.

At the core of CSS's long-term care review process is MTMPath™, a web-based software that pharmacists utilize to provide traditional consulting services, coordinate prior authorizations and create population-level reports.  MTMPath facilitates MDS data collection.  In many cases, the data can be downloaded directly into a long-term care facility's billing software.

Pharmacists using MTMPath will be able to consistently produce evidence-based recommendations for attending physicians and mid-levels, and track the recommendations so that their eventual disposition can be reported at quality meetings.  Because the software is web-based, clinicians can log into the software using any online Internet browser to review the patient's record and therapeutic regimen.

MTMPath algorithms evaluate drugs with regard to their clinical markers of effectiveness (i.e. lab results, signs and symptoms, behavioral charting, etc.) and a full Beers list evaluation can also be undertaken.  For many common geriatric therapies, MTMPath has integrated overuse and underuse recommendation templates for notifying physicians and mid-level providers of possible drug-related issues.

In addition, the software allows for a focused review of drug therapy within the facility (Warfarin use and average PTTs, bisphosphonates and corresponding DEXA results, etc.).  These focused reviews can provide Quality and P&T Committees with population-level, drug-use trends and effectiveness.  These types of focused reviews can also be used as the basis of clinical policy and procedure development, care plan management and P&T Committee decisions.

MTMPath also incorporates therapy-associated assessment tools (COPD, depression, pain, cardiovascular risk) that can be used to gauge patient status and improvement as a result of therapy intervention.

For more information about Medication Pathfinder™, our network of MTMPath users, click here.